UBS AM’s Recursion Pharmaceuticals RXRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $20.5M | Sell |
|
|||||
|
2025
Q2 | $23.4M | Sell |
|
|||||
|
2025
Q1 | $33.9M | Buy |
|
|||||
|
2024
Q4 | $15.3M | Buy |
|
|||||
|
2024
Q3 | $14.1M | Buy |
|
|||||
|
2024
Q2 | $15.7M | Buy |
|
|||||
|
2024
Q1 | $2.05M | Sell |
|
|||||
|
2023
Q4 | $2.24M | Buy |
|
|||||
|
2023
Q3 | $1.62M | Buy |
|
|||||
|
2023
Q2 | $769K | Hold |
|
|||||
|
2023
Q1 | $769K | Buy |
|
|||||
|
2022
Q4 | $824K | Buy |
|
|||||
|
2022
Q3 | $818K | Buy |
|
|||||
|
2022
Q2 | $419K | Buy |
|
|||||
|
2022
Q1 | $345K | Buy |
|
|||||
|
2021
Q4 | $607K | Buy |
|